FOXP3 and chronic obstructive pulmonary disease: Previous studies have demonstrated a decreased level of IL-10 in the serum of COPD stage III patients compared to patients with disease stages I and II [16] and to those with disease stages II and III, who also presented lower frequencies and numbers of Foxp3 mRNA transcripts compared with non-obstructed smokers [17].